TY  - JOUR
AU  - Mareque, María
AU  - Mingot-Castellano, María Eva
AU  - López-Fernández, María Fernanda
AU  - Álvarez-Román, María Teresa
AU  - Oyagüez, Itziar
PY  - 2020
DO  - 10.1111/ejh.13414
UR  - http://hdl.handle.net/10668/15295
T2  - European journal of haematology
AB  - This study estimated the cost of prophylaxis with activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa) in surgical patients with haemophilia A and inhibitors in Spain. A decision-analytic model was developed...
LA  - en
KW  - coagulation disorders
KW  - Blood Coagulation Factor Inhibitors
KW  - Clinical Decision-Making
KW  - Cost-Benefit Analysis
KW  - Disease Management
KW  - Drug Costs
KW  - Factor VIIa
KW  - Health Care Surveys
KW  - Hemophilia A
KW  - Hemorrhage
KW  - Humans
KW  - Isoantibodies
KW  - Recombinant Proteins
KW  - Spain
KW  - Surgical Procedures, Operative
TI  - Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain.
TY  - research article
VL  - 105
ER  -